PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $36.80 million. The enterprise value is $15.92 million.
| Market Cap | 36.80M |
| Enterprise Value | 15.92M |
Important Dates
The last earnings date was Tuesday, June 2, 2026, after market close.
| Earnings Date | Jun 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.03 million shares outstanding. The number of shares has increased by 1.58% in one year.
| Current Share Class | 21.03M |
| Shares Outstanding | 21.03M |
| Shares Change (YoY) | +1.58% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 7.78% |
| Owned by Institutions (%) | 24.42% |
| Float | 13.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.00 |
| PS Ratio | 0.21 |
| Forward PS | 0.15 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.84 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -100.44% and return on invested capital (ROIC) is -389.74%.
| Return on Equity (ROE) | -100.44% |
| Return on Assets (ROA) | -15.44% |
| Return on Invested Capital (ROIC) | -389.74% |
| Return on Capital Employed (ROCE) | -97.36% |
| Weighted Average Cost of Capital (WACC) | 8.35% |
| Revenue Per Employee | $947,201 |
| Profits Per Employee | -$303,101 |
| Employee Count | 189 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 8.64 |
Taxes
| Income Tax | -73,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.86% in the last 52 weeks. The beta is 0.77, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -49.86% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 2.56 |
| Relative Strength Index (RSI) | 32.56 |
| Average Volume (20 Days) | 209,726 |
Short Selling Information
The latest short interest is 530,504, so 2.52% of the outstanding shares have been sold short.
| Short Interest | 530,504 |
| Short Previous Month | 579,291 |
| Short % of Shares Out | 2.52% |
| Short % of Float | 3.91% |
| Short Ratio (days to cover) | 5.69 |
Income Statement
In the last 12 months, PetMed Express had revenue of $179.02 million and -$57.29 million in losses. Loss per share was -$2.74.
| Revenue | 179.02M |
| Gross Profit | 50.22M |
| Operating Income | -28.39M |
| Pretax Income | -57.36M |
| Net Income | -57.29M |
| EBITDA | -19.00M |
| EBIT | -28.39M |
| Loss Per Share | -$2.74 |
Balance Sheet
The company has $21.41 million in cash and $535,000 in debt, with a net cash position of $20.88 million or $0.99 per share.
| Cash & Cash Equivalents | 21.41M |
| Total Debt | 535,000 |
| Net Cash | 20.88M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 28.94M |
| Book Value Per Share | 1.37 |
| Working Capital | -8.47M |
Cash Flow
In the last 12 months, operating cash flow was -$28.39 million and capital expenditures -$4.62 million, giving a free cash flow of -$33.01 million.
| Operating Cash Flow | -28.39M |
| Capital Expenditures | -4.62M |
| Depreciation & Amortization | 9.39M |
| Net Borrowing | n/a |
| Free Cash Flow | -33.01M |
| FCF Per Share | -$1.57 |
Margins
Gross margin is 28.05%, with operating and profit margins of -15.86% and -32.00%.
| Gross Margin | 28.05% |
| Operating Margin | -15.86% |
| Pretax Margin | -32.04% |
| Profit Margin | -32.00% |
| EBITDA Margin | -10.61% |
| EBIT Margin | -15.86% |
| FCF Margin | n/a |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.58% |
| Shareholder Yield | n/a |
| Earnings Yield | -155.68% |
| FCF Yield | -89.71% |
Analyst Forecast
The average price target for PetMed Express is $2.15, which is 22.86% higher than the current price. The consensus rating is "Strong Sell".
| Price Target | $2.15 |
| Price Target Difference | 22.86% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 1.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 2 |